10.21147/j.issn.1000-9604.2019.05.06
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients
31
This study was supported by the Chinese Academic of Medical Sciences Initiative for Innovative Medicine CAMS-I2M-1-010
2019-12-09(万方平台首次上网日期,不代表论文的发表时间)
共12页
759-770